# A New Way to Study How Cannabis Use Impacts Safe Driving > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-impaired-driving-research-safe-driving/ > **Published:** 2026-02-24T17:06:31-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:14:19-04:00 > **Clinical Summary:** Explore cannabis impaired driving research and new testing methods that better reflect real-world safety beyond unreliable THC blood levels. --- ✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SafetyResearchPolicyTHCDosing Why This Matters If you use cannabis medicinally and drive, better research into impairment testing could eventually replace unreliable THC blood level thresholds with assessments that more fairly and accurately reflect whether you are actually safe behind the wheel. Clinical Summary As [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) continues to expand across the United States, research into how [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) affects driving performance remains critically underdeveloped, creating a significant gap between policy and [patient safety](https://cedclinic.com/indiana-marijuana-legalization-policy-addressing-lagging-reform/) evidence. New approaches to studying cannabis-impaired driving are essential because unlike alcohol, THC affects psychomotor function in highly variable ways depending on tolerance, dosing method, cannabinoid profile, and individual metabolism. Clinically, we need validated tools that reflect real-world impairment rather than relying solely on blood THC levels, which correlate poorly with actual functional impairment. Dr. Caplan’s Take “We have been punishing patients based on a blood THC number that tells us almost nothing about whether they can safely operate a vehicle, and it is long past time that science caught up with the policy we are already living under.” Clinical Perspective New research methodologies are being developed to better understand how cannabis actually affects driving, and this matters enormously for patients. For years, we have relied on blood THC levels as a proxy for impairment, but clinically I can tell you that a daily [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patient with stable tolerance and a THC-naive recreational user are worlds apart in terms of functional impairment. ️ The legal system has largely treated them the same, which is neither scientifically sound nor fair. What we need are validated, real-world impairment assessments that account for tolerance, route of administration, cannabinoid ratios, and individual pharmacokinetics. This kind of research is exactly what responsible legalization demands, and I am encouraged to see it getting the attention it deserves. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+A+new+way+to+%3Cb%3Estudy%3C%2Fb%3E+how+%3Cb%3Ecannabis%3C%2Fb%3E+use+impacts+safe+driving+%7C+EurekAlert%21+%40drcaplan&url=https%3A%2F%2Fwww.eurekalert.org%2Fnews-releases%2F1117628) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.eurekalert.org%2Fnews-releases%2F1117628) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+A+new+way+to+%3Cb%3Estudy%3C%2Fb%3E+how+%3Cb%3Ecannabis%3C%2Fb%3E+use+impacts+safe+driving+%7C+EurekAlert%21+%E2%80%94+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.eurekalert.org%2Fnews-releases%2F1117628) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.eurekalert.org/news-releases/1117628](https://www.eurekalert.org/news-releases/1117628) Further Reading Evidence Watch[Regulatory Digest 2026-03-08](https://cedclinic.com/regulatory-digest-2026-03-09/)CED Clinic Blog[Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years](https://cedclinic.com/cannabis-beverage-substitution-alcohol-new-york-five-years/)Policy Watch[Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I](https://cedclinic.com/dea-temporary-placement-schedule-i-n-desethyl-isotonitazene/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [THC levels in blood and urine are "unreliable" indicators of driving impairment – leafie](https://cedclinic.com/cannabis-impairment-testing-challenges-driving-safety/) This article discusses why THC blood and urine levels do not reliably indicate driving impairment, highlighting the need for better assessment methods. [Read More](https://cedclinic.com/cannabis-impairment-testing-challenges-driving-safety/) [Prescribed cannabis and driving behaviours among two samples of people who regularly … – UNSW](https://cedclinic.com/prescribed-cannabis-driving-behaviours-clinical-insights/) A study exploring driving behaviors in patients prescribed cannabis, providing insights into real-world impairment and safety considerations. [Explore Study](https://cedclinic.com/prescribed-cannabis-driving-behaviours-clinical-insights/) [Ever think about how we actually measure THC impairment in the real world? Because … – Facebook](https://cedclinic.com/thc-impairment-testing-challenges-real-world/) A discussion on the challenges and emerging methods for measuring THC impairment in real-world driving scenarios. [Join the Conversation](https://cedclinic.com/thc-impairment-testing-challenges-real-world/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).